Integrated Diagnostics Holdings PLC
LSE:IDHC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.2845
0.535
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Integrated Diagnostics Holdings PLC
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | JE |
Market Cap | 237.3m USD |
Gross Margin |
38%
|
Country | US |
Market Cap | 91.8B USD |
Gross Margin |
11%
|
Country | US |
Market Cap | 87.7B EUR |
Gross Margin |
11%
|
Country | US |
Market Cap | 73B USD |
Gross Margin |
14%
|
Country | DE |
Market Cap | 24.9B EUR |
Gross Margin |
25%
|
Country | US |
Market Cap | 20.1B USD |
Gross Margin |
28%
|
Country | DE |
Market Cap | 18.8B EUR |
Gross Margin |
24%
|
Country | US |
Market Cap | 18.3B USD |
Gross Margin |
33%
|
Country | US |
Market Cap | 13.7B USD |
Gross Margin |
33%
|
Country | DE |
Market Cap | 12.4B EUR |
Gross Margin |
25%
|
Country | AU |
Market Cap | 13.4B AUD |
Gross Margin |
84%
|
Integrated Diagnostics Holdings PLC
Glance View
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Integrated Diagnostics Holdings PLC's most recent financial statements, the company has Gross Margin of 37.7%.